Navigation Links
Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology

Protocol for New Aggrastat Study in American Heart Journal


WINNIPEG, Manitoba - (July 11, 2007) Medicure Inc. (TSX:MPH; Amex:MCU), a cardiovascular focused, biopharmaceutical company, today announced that the two-year, follow-up results from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare Metal Stent In Acute Myocardial Infarction) study were published in the July edition of the Journal of the American College of Cardiology (JACC).


The article, titled, "Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction", outlines the potential benefit of AGGRASTATR (tirofiban hydrochloride) plus sirolimus-eluting stent (SES) versus ReoproR (abciximab) plus bare-metal stent (BMS) in the prevention of the cumulative incidence of death, myocardial infarction (MI), or target vessel revascularization (TVR) in acute myocardial infarction patients after two years.


At two years, the cumulative incidence of death, MI, or TVR was lower in the AGGRASTATR-SES group compared with the ReoproR-BMS group (24.2% vs. 38.6%, p@038). This statistically significant outcome at two years is similar to the previously reported eight month results that were published in The Journal of the American Medical Association (May 2005).


The positive results from STRATEGY were the impetus for an ongoing larger factorial design study titled MULTI-STRATEGY (Multicentre Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab and Sirolimus-Eluting Stent Versus Base Metal Stent in Acute Myocardial Infarction). The MULTI-STRATEGY protocol was published in the July edition of the American Heart Journal.


This 600-patient study will further assess AGGRASTATR-S
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
11. Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
Post Your Comments:
(Date:7/28/2014)... NORWALK, Conn. , July 28, 2014  UBM ... , a leading online community for medical imaging professionals, ... value in value-based payment models . The ... in identifying how the radiologist,s reimbursement is determined ... article features insight from leaders in the field, who ...
(Date:7/28/2014)... Colo. , July 28, 2014  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer and Michael Carruthers ... call.Conference Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. ...
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
Breaking Medicine Technology:Diagnostic Imaging Delves into Measuring the Radiologist's Value 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... Feb. 25, 2011 HASCO Medical, Inc. (OTC Bulletin ... managed healthcare provider that serves patients in Alabama, Florida, ... offering making available an additional 8,000+ products available for ... now makes it easy and affordable for patients throughout ...
... Feb. 25, 2011 NorTech, in partnership with ... announce the winners of its annual Innovation Awards ... most innovative organizations and leaders. This ... awards, representing innovations from a broad range of ...
Cached Medicine Technology:HASCO Medical Expands Online Offering 2NorTech, Crain's Cleveland Business Announce 2011 Innovation Award Winners 2NorTech, Crain's Cleveland Business Announce 2011 Innovation Award Winners 3NorTech, Crain's Cleveland Business Announce 2011 Innovation Award Winners 4NorTech, Crain's Cleveland Business Announce 2011 Innovation Award Winners 5
(Date:7/28/2014)... 2014 Mediaplanet announced distribution ... March 12th, a campaign that aims to raise awareness ... with industry leader TEALUX , a premium loose ... the campaign provides readers with educational insight about the ... propel the industry forward and make conscious organic choices ...
(Date:7/28/2014)... Irresistible infants have met their match with a ... online gifting company specializes in homemade chicken noodle soup and creates ... package starts with home-from-the-hospital essentials every new parent will love:, ... rolls , 6 cookies , a ladle ... ready to heat and eat upon delivery, so parents can relax ...
(Date:7/28/2014)... 28, 2014 A St. Jude Children’s ... survivors of childhood cancer more than doubled their risk ... failing to follow a heart-healthy lifestyle. The results appear ... Almost 32 percent of the 1,598 adult survivors of ... umbrella term for health risk factors like high blood ...
(Date:7/28/2014)... Congress 2014 promises to be bigger, better and more ... of the Congress Programme Committee. The European Society of ... event every year in August. Record numbers of Hot ... the congress is on track to host the largest ... why an extra hot line session has been added ...
(Date:7/28/2014)... Taiwan has developed a new optical technology that may ... sooner, when it is more easily treated. If the ... may pave the way for the early detection and ... neuropathy, which is common among people with both Type ... the autonomic nerves controlling vital organs like the heart ...
Breaking Medicine News(10 mins):Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 3Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 4Health News:ESC Congress 2014 focuses on innovations in cardiology 2Health News:ESC Congress 2014 focuses on innovations in cardiology 3Health News:Wearable device for the early detection of common diabetes-related neurological condition 2
... point out that, consumption of bacon and other processed meat ... ,Dr Dominique S Michaud and other researchers from Boston’s Harvard ... more than 5 portions of bacon every week were more ... by 60% in those who eat bacon regularly, and by ...
... Commonly used drugs that are used in treatment of ... determined by a research, published by the Journal of ... in brain damage. The effects may be long lasting. ... 'chemobrain'.Chemobrain refers to the side effects that are seen ...
... Consumption of milk fortified with specific micronutrients—zinc, iron, ... E—significantly reduce diarrhea and acute lower// respiratory illness ... from the Johns Hopkins Bloomberg School of Public ... Annamalai University in India. The study was published ...
... over laden with salt especially the processed salty snacks instead ... difficulty for them to consume foods with lower concentration of ... intake. ,Disasters like childhood hypertension and early development ... many and can be corrected by reducing the salt content ...
... becoming exceedingly health conscious thus there is a noted ... population. It’s a known fact that moderate// consumption of ... not very safe for any health professional to recommend ... professional says,” I never advocate unrestrained intake. My recommendations ...
... Welfare is procuring a pre-fabricated, self-contained, container based mobile ... of art operation theatre, diagnostic facilities including CT scan, ... generator. ,This container based hospital would be ... road, rail or air to the disaster sites in ...
Cached Medicine News:Health News:Fortified Milk Reduces Morbidity in Preschool Children 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: